Bearden J D, Ratkin G A, Coltman C A
J Clin Pathol. 1974 Sep;27(9):738-40. doi: 10.1136/jcp.27.9.738.
The Jamshidi-Swaim biopsy needle was utilized to perform 205 bone marrow biopsies, accompanied by simultaneous bone marrow aspirates, on patients with lymphoma, leukaemia, and a variety of solid tumours. There was no significant morbidity. There were 67 positive findings with biopsy and 42 with aspiration. The two techniques were complementary in Hodgkin's disease, non-Hodgkin's lymphoma, breast carcinoma, bronchogenic carcinoma, malignant melanoma, and in leukaemia. We have examined the bone marrow biopsies and aspirates with respect to the adequacy of the bone marrow biopsy specimen, the number of positive biopsies in the various categories of neoplasia, and the disparity of biopsy and aspirate, finding that 28 of the 67 positive biopsies (41.8%) had negative aspirates. These data and specimens obtained compared quite favourably with other series in which a modification of the Vim-Silverman needle was used.
使用Jamshidi-Swaim活检针，对淋巴瘤、白血病和多种实体瘤患者进行了205次骨髓活检，并同时进行骨髓穿刺。未出现明显并发症。活检有67项阳性结果，穿刺有42项阳性结果。这两种技术在霍奇金病、非霍奇金淋巴瘤、乳腺癌、支气管癌、恶性黑色素瘤和白血病中具有互补性。我们检查了骨髓活检和穿刺样本，涉及骨髓活检标本的充足性、各类肿瘤中阳性活检的数量以及活检和穿刺结果的差异，发现67例阳性活检中有28例（41.8%）穿刺结果为阴性。与使用改良Vim-Silverman针的其他系列研究相比，我们获得的数据和标本相当不错。
